Speakers

Christian Arquint joined T3 Pharmaceuticals AG in early 2018. As head of clinical manufacturing and member of the CMC team he coordinates the development and manufacture of their innovative bacterial product, alongside the design and development of various analytical methods. Christian started his scientific career by studying the type of bacteria that T3 Pharmaceuticals AG’s therapy is based on during his master studies at University of Basel. He then moved on to study basic mechanisms of cell division in human cells during his PhD. After his academic studies, Christian reunited with a group of former colleagues that have meanwhile decided to found their own company, T3 Pharmaceuticals AG, with the goal to transform their academic knowledge into an effective anti-cancer treatment.

Presentation Title: Developing the Next Generation Bacterial Cancer Therapy

View company profile